UF College of Medicine-Jacksonville — Jacksonville, Florida

UF College of Medicine-Jacksonville is a clinical research site located in Jacksonville, Florida, United States 32209.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

UF College of Medicine-Jacksonville has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Alzheimer Disease, Diabetic Foot Ulcers, Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Lantheus Biosciences Ltd., Neogenix, LLC dba Ogenix, Jiangsu HengRui Medicine Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jacksonville

Browse all research sites in Florida · View every site in Jacksonville

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UF College of Medicine-Jacksonville?

UF College of Medicine-Jacksonville has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UF College of Medicine-Jacksonville conducted?

UF College of Medicine-Jacksonville has 3 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, Diabetic Foot Ulcers, Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is UF College of Medicine-Jacksonville accredited by Crixeo Clinical Trials?

UF College of Medicine-Jacksonville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UF College of Medicine-Jacksonville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.